IL-1β was described as an interleukin which creates a microenvironment conducive to the development of secondary cancer, together with increased fibroblast activity, stabilization in the transcription of the MMP-1 gene and collagens (Müerköster et al., 2004). The gene discussed is IL1B; the disease is cancer.